These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 32840470)
21. No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non-Small Cell Lung Cancer. Nam JG; Hong H; Choi SH; Park CM; Goo JM; Kim YT; Kim H Radiology; 2022 Jun; 303(3):632-643. PubMed ID: 35258373 [TBL] [Abstract][Full Text] [Related]
22. Prospective comparison of Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073 [TBL] [Abstract][Full Text] [Related]
23. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Yield and False-Referral Rate of Staging Chest CT in Patients with Colon Cancer. Lee KH; Park JH; Kim YH; Lee KW; Kim JW; Oh HK; Jeon JJ; Yoon H; Kim J; Lee KH Radiology; 2018 Nov; 289(2):535-545. PubMed ID: 30084734 [TBL] [Abstract][Full Text] [Related]
25. Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational? Zhuge L; Huang Y; Wang S; Xie J; Huang B; Zheng D; Zheng S; Zhao Y; Mao H; Wilson DO; Luketich JD; Xiang J; Chen H; Zhang J J Cancer Res Clin Oncol; 2019 Feb; 145(2):503-509. PubMed ID: 30536037 [TBL] [Abstract][Full Text] [Related]
26. Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms. Ando T; Kage H; Saito M; Amano Y; Goto Y; Nakajima J; Nagase T Int J Clin Oncol; 2018 Aug; 23(4):641-646. PubMed ID: 29484515 [TBL] [Abstract][Full Text] [Related]
27. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center. Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831 [TBL] [Abstract][Full Text] [Related]
28. Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer? Imai K; Kurihara N; Konno M; Mori N; Takashima S; Kuriyama S; Demura R; Suzuki H; Harata Y; Fujibayashi T; Shibano S; Wakita A; Nagaki Y; Sato Y; Nomura K; Minamiya Y Cancer Imaging; 2024 Jun; 24(1):69. PubMed ID: 38831467 [TBL] [Abstract][Full Text] [Related]
29. CT Features of Epidermal Growth Factor Receptor-Mutated Adenocarcinoma of the Lung: Comparison with Nonmutated Adenocarcinoma. Hasegawa M; Sakai F; Ishikawa R; Kimura F; Ishida H; Kobayashi K J Thorac Oncol; 2016 Jun; 11(6):819-26. PubMed ID: 26917231 [TBL] [Abstract][Full Text] [Related]
30. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer. Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
32. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary? Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165 [TBL] [Abstract][Full Text] [Related]
33. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. Morgensztern D; Ng SH; Gao F; Govindan R J Thorac Oncol; 2010 Jan; 5(1):29-33. PubMed ID: 19952801 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer]. Ozgül MA; Uysal MA; Kadakal F; Altoparlak B; Cinemre H; Yilmaz V Tuberk Toraks; 2006; 54(3):229-34. PubMed ID: 17001539 [TBL] [Abstract][Full Text] [Related]
37. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study. Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530 [TBL] [Abstract][Full Text] [Related]
38. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382 [TBL] [Abstract][Full Text] [Related]
39. Clinical and computed tomography characteristics of non-small cell lung cancer with ALK gene rearrangement: Comparison with EGFR mutation and ALK/EGFR-negative lung cancer. Mori M; Hayashi H; Fukuda M; Honda S; Kitazaki T; Shigematsu K; Matsuyama N; Otsubo M; Nagayasu T; Hashisako M; Tabata K; Uetani M; Ashizawa K Thorac Cancer; 2019 Apr; 10(4):872-879. PubMed ID: 30811109 [TBL] [Abstract][Full Text] [Related]
40. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]